Abstract
This chapter discusses the molecular structure of botulinum toxin and its mode of action on muscles, glands and peripheral nerves.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rossetto O. Chapter 1: Botulinum toxins: Molecular structures and synaptic physiology. In: Jabbari B, editor. Botulinum toxin treatment in clinical medicine-a disease oriented approach. New York: Springer; 2017. p. 1–12.
Monteccuco C, Rasso MB. On botulinum neurotoxin variability. MBio. 2015:6e02131.
Lacy DB, Tepp W, Cohen AC, DasGupta BR, Stevens RC. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol. 1998;5:898–902.
Rothman JE. The principle of membrane fusion in the cell (Nobel lecture). Angew Chem Int Ed Engl. 2014;53(47):12676–94. https://doi.org/10.1002/anie.201402380.Epub2014A.
Blasi J1, Chapman ER, Link E, Binz T, Yamasaki S, De Camilli P, Südhof TC, Niemann H, Jahn R. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature. 1993;365(6442):160–3.
Kumar R, Dhaliwal HP, Kukreja RV, Singh BR. The botulinum toxin as a therapeutic agent: molecular structure and mechanism of action in motor and sensory systems. Semin Neurol. 2016;36:10–9.
Aurora SK, Winner P, Freeman MC, Spierings EL, Heiring JO, DeGryse RE, VanDenburgh AM, Nolan ME, Turkel CC. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program. Headache. 2011;51:1358–73.
Jabbari B. Botulinum toxin treatment of pain disorders. New York: Springer; 2015.
Lacković Z, Filipović B, Matak I, et al. Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches. Br J Pharmacol. 2016;173:279–91.
Bach-Rojecky L, Salković-Petrisić M, Lacković Z. Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection. Eur J Pharmacol. 2010;633:10–4.
Wang J, Casals-Diaz L, Zurawski T, et al. A novel therapeutic with two SNAP-25 inactivating proteases shows long-lasting anti-hyperalgesic activity in a rat model of neuropathic pain. Neuropharmacology. 2017;118:223–32.
Pirrazzini M, Rossetto O, Elopra R, Montecucco C. Botulinum neurotoxins: biology, pharmacology, and toxicology. Pharmacol Rev. 2017;69:200–35.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jabbari, B. (2018). Basics of Structure and Mechanisms of Function of Botulinum Toxin - How Does it Work?. In: Botulinum Toxin Treatment . Springer, Cham. https://doi.org/10.1007/978-3-319-99945-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-99945-6_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99944-9
Online ISBN: 978-3-319-99945-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)